GlassScriptPhysician profile
Justin Michael Quinette
NPI 1043873904
$1,851.59
in general payments reported to CMS, 2019-2025
19 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $110 · 2021: $380 · 2022: $477 · 2023: $490 · 2024: $200 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $291.84 | 2022 | |
| Exact Sciences Corporation | $188.03 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $168.09 | 2021-2024 | Farxiga, Breztri |
| Boston Scientific Corporation | $144.13 | 2025 | Ams 700 Cxr Rte Kit |
| Abbvie INC. | $140.52 | 2022-2024 | |
| Horizon Therapeutics Plc | $122.58 | 2023 | Krystexxa |
| Linvatec Corporation | $110.30 | 2020 | |
| Amgen INC. | $110.04 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $96.03 | 2021 | |
| Atricure, INC. | $92.87 | 2023 | |
| Sanofi-Aventis U.S. LLC | $91.71 | 2021 | |
| Glaxosmithkline, LLC. | $85.87 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $66.37 | 2022 | |
| Hydrocision, INC. | $36.86 | 2024 | Tenjet |
| Trice Medical, INC. | $32.67 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.65 | 2023 | |
| Bioventus LLC | $17.54 | 2025 | Durolane |
| Merck Sharp & Dohme LLC | $16.16 | 2024 | Capvaxive, Gardasil 9, Gardasil |
| Kowa Pharmaceuticals America, INC. | $15.33 | 2023 | Livalo, Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Quinette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.